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The gastric mucus is an important factor for protection of
the gastric mucosal epithelium against digestive juice. The
cDNAs of the human gastric mucin core peptides have been
partially or fully cloned, and the existence of MUC1-8 was
confirmed in various organs.1) Mucins are classified into two
types according to their biochemical characteristics, mem-
brane-associated and secreted mucins. Moreover, the se-
creted mucins are divided into two subgroups, gel-forming
and soluble mucins. MUC5AC and MUC6 are mainly found
in the stomach, and are produced in surface mucous cells and
mucous neck cells, respectively.2) Because of the difficulty in
estimating the mucin molecular species, the uptake of the 14C
or 3H labeled glucosamine into the sugar chain has usually
been examined as the index of gastric mucus secretion and
biosynthesis.3)
On the other hand, ulcerogenic side effects of glucocorti-
coids on the gastric mucosa, and inhibition of gastric mucus
secretion and biosynthesis was determined in an early
study.4) The enhancement of mRNA expression and biosyn-
thesis of the pepsinogen (Pg) which is one of the aggressive
factors in a gastric ulcer, was later reported using adrenalec-
tomized and glucocorticoid administered rats.5) In spite of
the importance of MUC5AC as a secretory gel-forming
mucin in the gastric barrier, regulation of MUC5AC mRNA
expression by glucocorticoid in the stomach has not yet been
shown. 
In this study, we examined the rat MUC5AC (rMUC5AC)
mRNA level as an index of the gastric mucin biosynthesis.
We demonstrated the effects of hydrocortisone on the expres-
sion of rMUC5AC mRNA in the adrenalectomized and nor-
mal rat stomach, comparing them with those on the expres-
sion of Pg mRNA. We also examined the direct effect of hy-
drocortisone using the cultured rat gastric epithelial cells.
MATERIALS AND METHODS
Chemicals Hydrocortisone acetate was purchased from
Wako Pure Chemical Industries (Osaka, Japan). Biotinylated
soybean agglutinin (SBA) and horseradish peroxidase-avidin
D (HRP-avidin D) were from Vector Laboratories, Inc.
(Burlingame, CA, U.S.A.). Dispase I and bovine serum albu-
min (BSA) (fraction V) were from Godo Shusei Co. (Tokyo,
Japan) and Sigma Chem. Co. (St. Louis, MO, U.S.A.). Im-
mobilon polyvinylidene difluoride (PVDF) transfer mem-
brane was from Japan Millipore, Ltd. (Tokyo, Japan). Anti-
sense oligodeoxynucleotides for rMUC5AC and Pg mRNA
were customized by Greiner Japan (Tokyo, Japan), as fol-
lows: rMUC5AC, 59-GGTGGTGAGCTGGTGTGGGTTGT-
39, which was estimated by Inatomi et al.,6) and for Pg, 59-
TGTGTCTACAATGCCTTGGCAGCCCTG-39, which was
estimated by Ichihara, et al.,7) then labeled by 32P with the
Oligonucleotide 59-End Labeling System (Du Pont NEN
Res. Pro., Boston, MA, U.S.A.). All other reagents were of
the best commercial quality available.
Preparation of Adrenalectomy and Treatment with Hy-
drocortisone Male Wistar rats weighing about 200 g were
used in experiments. Adrenalectomy was performed follow-
ing the method of Grollman.8) After adrenalectomy, rats were
maintained with free access to food and saline instead of tap
water for one week. Three doses of hydrocortisone (1, 5 and
50 mg/kg in olive oil) were subcutaneously injected into the
animals once a day for 3 d. At the end of the treatment, rats
were starved for 24 h and were sacrificed under ether anes-
thesia.
Extraction of RNA and Northern Blot Analysis Total
RNA was extracted from the glandular portion of the stom-
ach or cultured epithelial cells by the acid guanidium thio-
cyanate–phenol–chloroform method.9) Northern blot hy-
bridization was carried out according to the standard
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The gastric mucus is an important factor in the gastric mucosal protection from acid, pepsin and various
reagents (alcohol, aspirin, etc.). MUC5AC is the mucin secreted from surface mucous cells, and belongs to the
gel-forming mucin. We examined the regulation of rat MUC5AC (rMUC5AC) mRNA by glucocorticoid in vivo
and in vitro, comparing it with that of pepsinogen (Pg) mRNA. By adrenal gland resection, rMUC5AC and Pg
mRNA levels and Pg content in rats significantly decreased to 70%, 46% and 42% of those in the sham operated
controls, respectively. With the treatment of hydrocortisone (1, 5 and 50 mg/kg), Pg mRNA level and Pg content
in adrenalectomized rats was restored. On the other hand, the rMUC5AC mRNA level exceeded the control with
1 or 5 mg/kg injections of hydrocortisone, but drastically decreased to 18% of sham operation levels with it (50
mg/kg). Similar results were obtained in normal rats with the treatment of hydrocortisone (50 mg/kg). Mucus
and DNA content of cultured rat gastric epithelial cells were not affected by hydrocortisone, but rMUC5AC
mRNA level was significantly decreased in a dose-dependent manner. 
From the in vivo and in vitro results, at least a physiological concentration of glucocorticoid was necessary in
the expression of rMUC5AC mRNA. However, high dose of hydrocortisone directly suppressed the expression of
rMUC5AC mRNA. These results suggested that hydrocortisone might directly cause the suppression and indi-
rectly the enhancement of the mucin biosynthesis. 
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method.10) Briefly, the electrophoresis of 5—10 mg of total
RNA was carried out in 1.0% agarose formalin gel. RNA in
gel was transferred onto a sheet of nylon membrane (Geen
Screen; NEN Life Sci. Pro., Inc., Boston, MA, U.S.A.) by
capillary action. The membrane was prehybridized for 4 h at
58 °C in a prehybridization buffer. After hybridization for
18 h at 58 °C with antisense rMUC5AC or Pg 32P-oligo-
deoxynucleotide, the membrane was washed twice with 0.1%
sodium dodecylsulfate (SDS) in 23SSC (13SSC; 16.6 mM
sodium chloride, 16.6 mM sodium citrate) buffer at room
temperature for 5 min, and twice with 0.1% SDS in
0.13SSC buffer at 50 °C for 15 min. After exposing a sheet
of X-ray film to the membrane, the obtained autoradiogram
was analyzed by NIH Image software, in which values were
corrected by the amount of rRNA. 
Culture of Rat Gastric Epithelial Cells and Treatment
with Hydrocortisone Culture of rat epithelial cells was
prepared by our method as previously described.11) Briefly,
everted sacs of the stomachs were filled with medium, im-
mersed in incubation medium containing Dispase I
(1 kU/ml), and gassed with 95% O2 and 5% CO2 at 37 °C for
1 h. Mucosal cells were gently isolated from the surface of
the gastric mucosa by pipetting. Cells obtained (23106
cells/dish) were inoculated on plastic dishes (35 mm diame-
ter) covered with collagen gel, and cultured in a Dulbecco’s
modified eagle medium–Ham’s F12 (1 : 1) medium (GIBCO
BRL/Life Tech., Eggenstein, Germany) supplemented with
10% fetal calf serum (Biofluids, Inc., Rockville, MD, U.S.A.)
and 100 mg/ml gentamicin sulfate at 37 °C for 24 h in a CO2
incubator. After the 24 h culture, hydrocortisone was added
to final concentrations of 0.1, 1 and 10 mg/ml and incubated
at 37 °C for 24 h in a CO2 incubator.
Measurement of Pepsinogen The homogenate of the
glandular portion of the stomach (10%) with 50 mM phos-
phate buffer (pH 7.5) was centrifuged at 100003g for 10 min
after freezing and thawing. The supernatant was used to mea-
sure peptic activity by the method of Anson and Mirsky,12)
and protein concentrations by the method of Bradford (Bio-
Rad Protein Assay; Bio-Rad Lab. Co., Richmond, CA,
U.S.A.).13)
Measurement of Mucin and DNA in Cultured Epithe-
lial Cells A dot blot analysis was used for the measurement
of mucin. Samples or various concentrations of purified gas-
tric mucin in 4 M guanidine hydrochloride were applied in a
microfiltration apparatus (Immunodot, Atto Co., Ltd., Tokyo)
and adsorbed onto a sheet of PVDF-membrane by aspiration.
After blocking the blotted sheet with 3% BSA in TBS-T
(0.05% tween 20 in 50 mM tris HCl buffered saline (pH 7.3))
at room temperature for 30 min and washing it with TBS-T,
the sheet was incubated with 5 mg/ml biotinylated-SBA in
0.1% BSA and 1 M NaCl in TBS-T for 30 min and washed 6
times with TBS-T at room temperature for 5 min. The same
procedure was carried out for HRP-avidin D. Enzyme activ-
ity was measured with 0.03% H2O2 and 0.02% 3-amino-9-
ethylcarbazole in 50 mM acetate buffer (pH 5). DNA concen-
tration of the cultured epithelial cells was measured using a
method of fluorescence enhancement of 49,6-diamidino-2-
phenylindole (DAPI).14)
Statistical Analysis The results were expressed as
mean6S.E. Data were analyzed using Student’s t-test for
paired comparison. The statistical significance of the differ-
ences in the dose-response was determined by analysis of
variance.
RESULTS
Effects of Hydrocortisone on rMUC5AC and Pg mRNA
Level and Pg Content in Adrenalectomized Rats Hydro-
cortisone was subcutaneously injected into adrenalectomiz-
ed rats once a day for 3 d one week after the operation.
rMUC5AC and Pg mRNA levels and Pg content were signifi-
cantly decreased by the adrenalectomy to 70%, 46% and
42% of sham operation levels, respectively (Fig. 1). With the
injections of hydrocortisone (1, 5 and 50 mg/kg), Pg mRNA
level and Pg content were restored (Fig. 1B). On the other
hand, the rMUC5AC mRNA level recovered to sham opera-
tion levels by injection of hydrocortisone (1 and 5 mg/kg),
but was drastically decreased to 18% by the injection of hy-
drocortisone (50 mg/kg) (Fig. 1A). With the injections of
hydrocortisone (1 and 5 mg/kg) into normal rats, the
rMUC5AC mRNA level increased to 164% and 171% of
control, respectively. However, with its injection at 50 mg/kg,
this level decreased to 38% (Fig. 2A).
Effects of Hydrocortisone on rMUC5AC mRNA Level
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Fig. 1. Effects of Hydrocortisone on rMUC5AC and Pg mRNA Levels
and Pg Content in Adrenalectomized Rats
Hydrocortisone (0, 1, 5 and 50 mg/kg; s.c.) was injected into adrenalectomized rats
once a day for 3 d one week after the operation. Each mRNA level (closed columns) is
shown as % of sham operation level, and Pg content (U/mg protein) as peptic activity12)
(open columns). Each value is the mean6S.E. of 4 experiments. * p,0.05, ** p,0.01
(V.S. sham) and # p,0.05 (V.S. 0 mg/kg) (ANOVA).
Fig. 2. Effects of Hydrocortisone on rMUC5AC and Pg mRNA Levels
and Pg Content in Normal Rats
Hydrocortisone (0, 1, 5 and 50 mg/kg; s.c.) was injected into adrenalectomized rats
once a day for 3 d. Each mRNA level (closed columns) is shown as % of the control,
and Pg content (U/mg protein) as peptic activity12) (open columns). Each value is the
mean6S.E. of 4 experiments. * p,0.05 (ANOVA).
and Mucus and DNA Content in Cultured Gastric Ep-
ithelial Cells The changes in mucus content, rMUC5AC
mRNA level and DNA content in cultured rat gastric epithe-
lial cells for 96 h are shown in Fig. 3; all three factors
reached a peak at 72 h. However, the ratios of mucus/DNA
were almost the same during the culture.
Hydrocortisone was added to the culture medium 24 h
after inoculation and the cells were incubated for 24 h, after
which, mucus content, rMUC5AC mRNA level and DNA
content were measured. Mucus and DNA contents were not
affected by hydrocortisone, however, the expression of
rMUC5AC mRNA was significantly decreased to 41% of the
control (Fig. 4).
DISCUSSION
It is well known that glucocorticoid is essential for matura-
tion in gastrointestinal development and it has an ulcerogenic
side effect on the gastric mucosa.4,15) A pharmacological dose
of corticosteroids usually inhibits phospholipase A2 via the
lipocortin, while there are reports that glucocorticoid does
not inhibit prostaglandin synthesis in the gastric mucosa.16)
We therefor examined the effect of hydrocortisone on the ex-
pression of rMUC5AC mRNA in the rat gastric mucosa, and
compared it with that on Pg mRNA. After adrenalectomy,
rMUC5AC and Pg mRNA levels and Pg content were signifi-
cantly decreased. With the treatment of hydrocortisone (1
and 5 mg/kg) the rMUC5AC mRNA level was restored to the
sham operation level, whereas by the treatment of hydrocorti-
sone (50 mg/kg), it drastically dropped to 18% of sham oper-
ation level, much lower than that of the adrenalectomized
rats. On the other hand, Pg mRNA level and Pg content in-
creased with the treatment of hydrocortisone (1, 5 and 50
mg/kg). Similar results with hydrocortisone treatment were
also obtained in normal rats. There is a report that the gastric
mesenchyme secretes humoral factors that are induced by
glucocorticoids.17) The reduction of the rMUC5AC mRNA
level by the adrenalectomy showed that a physiological con-
centration of glucocorticoid was necessary at least for the ex-
pression of rMUC5AC mRNA. Therefore, increase in the
rMUC5AC mRNA levels might be induced by certain fac-
tors, one of which is from gastric mesenchyme with the treat-
ment of an appropriate amount of hydrocortisone. The de-
crease in the rMUC5AC mRNA level by the treatment with
hydrocortisone (50 mg/kg) was thought to be the sum total of
enhancement and suppression, different from Pg. This dis-
crepancy shows the existence of two mechanisms in vivo: hy-
drocortisone increases or decreases mucin mRNA expression
both directly and indirectly.
Based on the above results, we examined whether or 
not hydrocortisone regulates the expression of rMUC5AC
mRNA directly, using cultured rat gastric mucosal epithelial
cells. We reported earlier the mucus secretion from cultured
rat gastric epithelial cells.11) In this study, we confirmed that
rMUC5AC mRNA was expressed in mucosal cells of our es-
tablished primary monolayer culture. Hydrocortisone sup-
pressed the expression of rMUC5AC mRNA in mucosal cell
culture in a dose-dependent manner, although it did not affect
mucus or DNA content. These results suggested that hydro-
cortisone (0.1—10 mg/ml) directly suppressed the expression
of rMUC5AC mRNA in gastric epithelial cells without af-
fecting the cellular viability. There is a report that dexam-
ethasone directly suppressed gastric mucin secretion and ex-
pression of MUC1 mRNA on the human stomach in vitro.18)
Our study had similar results on this point. In this culture
system, epithelial cells continuously expressed rMUC5AC
mRNA, although the existence of a trace amount of gluco-
corticoid in fetal calf serum was not absolutely ruled out.
Taking in vivo and in vitro results into consideration, the
expression of rMUC5AC mRNA might be balanced by indi-
rect enhancement by a certain factor that is regulated by hy-
drocortisone, from other cells like mesenchyme, and by di-
rect suppression by hydrocortisone. Therefore, pharmacolog-
ical doses of glucocorticoids increase synthesis of Pg, and in-
hibit mucin biosynthesis, that is, they induce the reinforce-
ment of an aggressive factor and the declination of a protec-
tive factor. Suppression of rMUC5AC in the epithelial cells
also seems to be involved in the pathogenesis of the steroid
therapy-induced gastric mucosal damage.
REFERENCES
1) Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J.,
636 Vol. 24, No. 6
Fig. 3. Changes of rMUC5AC mRNA Level, and Mucin and DNA Con-
tent in the Rat Gastric Epithelial Cells during Culture
(A) Top panel is a Northern blot of rMUC5AC mRNA, and lower panel is ethidium
bromide dyeing of 28 s. (B) Mucin (closed columns) and DNA content (closed circles)
were measured according to the method in the text. Each value is the mean6S.E. of 5
experiments. * p,0.05 (V.S. 24 h).
Fig. 4. Effects of Hydrocortisone on rMUC5AC mRNA Level and Mucus
and DNA Content in the Cultured Rat Gastric Epithelial Cells
Gastric epithelial cells were cultured for 24 h. After that, hydrocortisone (0.1—10
mg/ml) was added to the medium, and cells were incubated for 24 h. rMUC5AC mRNA
level (closed triangle), and mucus (closed circle) and DNA (open circle) content were
shown as % of control. Each value is the mean6S.E. of 4 experiments. * p,0.05
(ANOVA).
J. Biol. Chem., 263, 12820—12823 (1988); Gum J. R., Hicks J. W.,
Toribara N. W., Siddiki B., Kim Y. S., ibid., 269, 2440—2446 (1994);
Gum J. R., Hicks J. W., Swallow D. M., Lagace R. L., Byrd J. C., Lam-
port D. T. A., Siddiki B., Kim Y. S., Biochem. Biophys. Res. Commun.,
171, 407—415 (1990); Porchet N., Cong N. V., Dufosse J., Audie J. P.,
Guyonnet-Duperat V., Gross M. S., Denis C., Degand P., Bernheim A.,
Aubert J. P., ibid., 175, 414—422 (1991); Guyonnet-Duperat V., Audie
J. P., Debailleul V., Laine A., Buisine M. P., Galiegue-Zouitina S.,
Pigny P., Degand P., Aubert J. P., Porchet N., Biochem. J., 305, 211—
219 (1995); Meerzaman D., Charles P., Daskal E., Polymeropoulos M.
H., Martin B. M., Rose M. C., J. Biol. Chem., 269, 12932—12939
(1994); Toribara N. W., Roberton A. M., Ho S. B., Kuo W. L., Gum E.,
Hicks J. W., Gum J. R., Jr., Byrd J. C., Siddiki B., Kim Y. S., ibid., 268,
5879—5885 (1993); Bobek L. A., Tsai H., Biesbrock A. R., Levine
M. J., ibid., 268, 20563—20569 (1993); Shankar V., Pichan P., Eddy
R. L., Tonk V., Nowak N., Sait S. N. J., Shows T. B., Schultz R. E.,
Gotway G., Elkins R. C., Gilmore M. S., Sachdev G. P., Am. J. Respir.
Cell Mol. Biol., 16, 232—241 (1997).
2) Seregni E., Botti C., Massaron S., Lombardo C., Capobianco A.,
Bogni A., Bombardieri E., Tumori., 83, 625—632 (1997); Reid C. J.,
Harris A., Gut, 42, 220—226 (1998).
3) Ichikawa T., Ishihara K., Kusakabe T., Kawakami T., Hotta K., Eur. J.
Pharmacol., 366, 87—92 (1999); Idem, Life Sci., 65, PL41—46
(1999).
4) Menguy R., Masters Y. F., Surgery., 54, 19—28 (1963).
5) Tsukada S., Ichinose M., Tatematsu M., Tezuka N., Yonezawa S.,
Kakei N., Matsushima M., Miki K., Kurokawa K., Kageyama T., Taka-
hashi K., Fukamachi H., Biochem. Biophys. Res. Commun., 202, 1—9
(1994).
6) Inatomi T., Tisdale A. S., Zhan Q., Spurr-Michaud S., Gipson I. K.,
Biochem. Biophys. Res. Commun., 236, 789—797 (1997).
7) Ichihara Y., Sogawa K., Morohashi K., Fujii-Kuriyama Y., Takahashi
K., Eur. J. Biochem., 161, 7—12 (1986).
8) Grollman A., Endocrinology, 29, 855—861 (1941).
9) Chomczynski P., Sacchi N., Anal. Biochem., 162, 156—159 (1987).
10) Sambrook J., Fritsch E. F., Maniatis T., “Molecular Cloning,” 2nd ed.,
Cold Spring Harbor Laboratory Press, 1989, pp. 7.37—7.51.
11) Tani S., Okuda M., Morishige R., Tanaka T., Biol. Pharm. Bull., 20,
482—485 (1997).
12) Anson M. L., Mirsky A. E., J. Gen. Physiol., 16, 59—63 (1932).
13) Bradford M. M., Anal. Biochem., 72, 248—254 (1976).
14) Clifford F. B., Kenneth C. J., Thomas W. J., Anal. Biochem., 92, 497—
500 (1979).
15) Henning S. J., Am. J. Physiol., 235, E451—E456 (1978).
16) Wallace J. L., Prostaglandins, 34, 311—323 (1987); Cirino G., Sor-
rentino L., Agents Actions, 18, 535—537 (1986).
17) Tsukada S., Ichinose M., Yahagi N., Matsubara Y., Yonezawa S., Shio-
kawa K., Furihata C., Miki K., Fukamachi H., Differentiation, 62,
239—247 (1998).
18) Okazaki K., Chiba T., Hajiro K., J. Clin. Gastroenterol., 27, S91—S96
(1998).
June 2001 637
